Akebia Therapeutics AKBA
NASDAQ AKBA
$0.57 +0.03 (+5.89%)
At close: Nov 11, 2026 · 4:00 PM EST

Akebia Therapeutics (AKBA) Net Short-Term Debt Issued (Repaid) (2019 - 2026)

Updated

Akebia Therapeutics (AKBA) recorded Current Debt of $237,000 in FY2014.

Analysis

Akebia Therapeutics (AKBA) Net Short-Term Debt Issued (Repaid) (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net ST Debt (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -5.28 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.28 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -499.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -682.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -87.00 Mn
10 Akebia Therapeutics 149.86 Mn -512.48 Mn 30.54 Mn 5.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 5.41 Mn
Mar 31, 2019 -15.00 Mn
API Access

Akebia Therapeutics Net Short-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=AKBA&period=max&api_key=YOUR_API_KEY